Markets
Creative Medical Technology Holdings, Inc. (CELZ)
CELZNASDAQ-CMBiotechnology: Biological Products (No Diagnostic Substances)
$0.6399
+0.0102 (+1.62%) today
Regular session, Nov 12, 1:30 PM ET
+1.62% 1D
- Market cap
- $4.86m
- P/E
- –
- EPS, last 4 quarters
- $-1.99
- Dividend yield
- –
- Day range
- $0.6100 to $0.6300
- 52-week range
- $0.5901 to $4.72
- Average volume
- –
- Previous close
- $0.6297
Analysts
1 coveringBuy1 buy, 0 hold, 0 sell
Targets a year out average $20.00, +3025.5% from here
$20.00now $0.6399$20.00
Earnings
next estimate $-0.3800Next report
Dec 2025
-116.2%
Mar 2026
+2.6%
Jun 2026
-5.1%
Sep 2026
-66.7%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | $3,000 | – | – |
| Gross profit | – | $2,000 | – | – |
| Operating income | -$1.27m | -$1.95m | -$1.46m | -$1.56m |
| Net income | -$1.24m | -$1.89m | -$1.41m | -$1.51m |
News
8 latest- Creative Medical Reports 93% Response Rate In Ultrasome Knee Osteoarthritis Pilot Study RTTNews · Oct 20, 2026
- Creative Medical Expands Ultrasome Intellectual Property Portfolio RTTNews · Sep 18, 2026
- Creative Medical Completes ADAPT Trial Enrollment; Advances Olastrocel; Stock Up RTTNews · Aug 20, 2026
- Top Biotech Gainers: CELZ Soars On Patent News, BRVE Debuts Strong, IOVA Revenue Climbs 66% RTTNews · Aug 6, 2026
- Creative Medical Technology Issues 2026 Mid-Year Update; Stock Down RTTNews · Jul 1, 2026
- Creative Medical Technology Holdings Secures $4.5 Million Through Warrant Exercises RTTNews · Jul 1, 2026
- Creative Medical Technology Expands ADAPT Trial After New FDA Clearance RTTNews · Jun 23, 2026
- Creative Medical Technology Advances Project PHOENIX Into National Wide AI-Driven Data Collection RTTNews · Jun 16, 2026
The company
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is a clinical-stage biotechnology company developing regenerative medicine technologies, including cell-based and cell-free approaches, targeting significant unmet medical needs.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ-CM
- Region
- North America
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.